Skip to main content

Table 2 Developmental outcomes from the Bayley Scales of Infant and Toddler Development (Bayley-III)

From: The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial

Outcome

Iodine (n = 27)

Placebo (n = 26)

Treatment effect (95 % CI)

P value

Cognitive Standardised Scorea

99.4 (12.2)

101.7 (8.2)

−2.3 (−7.8, 3.2)

0.42

Language Standardised Scorea

97.2 (12.2)

97.9 (11.5)

−0.7 (−7.0, 5.6)

0.83

Motor Standardised Scorea

93.9 (10.8)

92.4 (9.7)

1.4 (−4.0, 6.9)

0.61

Social-Emotional Standardised Scorea

105.8 (15.9)

105.4 (16.2)

0.4 (−8.5, 9.3)

0.93

Adaptive Behaviour Standardised Scorea

105.2 (15.2)

103.5 (14.9)

1.8 (−6.4, 10.0)

0.67

Cognitive scoreb <85

1 (3.7)

0 (0.0)

N/A

>0.99

Cognitive scoreb <70

1 (3.7)

0 (0.0)

N/A

>0.99

Language scoreb <85

3 (11.1)

3 (11.5)

N/A

>0.99

Language scoreb <70

0 (0.0)

0 (0.0)

N/A

N/A

Motor scoreb <85

2 (7.4)

5 (19.2)

N/A

0.25

Motor scoreb <70

1 (3.7)

0 (0.0)

N/A

>0.99

  1. CI confidence interval, N/A not applicable
  2. aThe data are presented as mean (standard deviation), and the treatment effect is the difference in means
  3. bThe data are presented as number (percentage)